American Journal of Clinical Nutrition, Vol 54, 98-103, Copyright © 1991 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia

D Laurin, H Jacques, S Moorjani, FH Steinke, C Gagne, D Brun and PJ Lupien
Departement de nutrition humaine et de consommation, Universite Laval, Quebec, Canada.

The effects of soy protein (35% of protein energy) given as a beverage and those of cow-milk proteins were investigated on plasma lipoprotein concentrations in children with familial hypercholesterolemia (FH). Subjects were randomly assigned to either the soy-protein or cow-milk- protein experimental period, with subsequent crossover after a washout period, each period lasting 4 wk. Diets were planned to provide 20% energy as protein, 28% as fat (polyunsaturated:monounsaturated:saturated fatty acids, 1:3:3) and less than 200 mg cholesterol/d. No changes were observed in either plasma cholesterol, low-density-lipoprotein cholesterol, or apolipoprotein concentrations. However, the soy beverage significantly reduced the concentrations of triglyceride and very-low-density-lipoprotein cholesterol (P less than 0.05) and significantly increased the concentrations of high-density-lipoprotein cholesterol (HDL-C) and HDL3- C (P less than 0.04 and P less than 0.03, respectively). These results indicate that the administration of soy protein may induce clinically beneficial effects in children with FH.

This article has been cited by other articles:

				P. O. Kwiterovich Jr. Recognition and Management of Dyslipidemia in Children and Adolescents J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4200 - 4209. [Abstract] [Full Text] [PDF]

				E. M. Haney, L. H. Huffman, C. Bougatsos, M. Freeman, R. D. Steiner, and H. D. Nelson Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force Pediatrics, July 1, 2007; 120(1): e189 - e214. [Abstract] [Full Text] [PDF]

				B. W. McCrindle, E. M. Urbina, B. A. Dennison, M. S. Jacobson, J. Steinberger, A. P. Rocchini, L. L. Hayman, and S. R. Daniels Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing Circulation, April 10, 2007; 115(14): 1948 - 1967. [Abstract] [Full Text] [PDF]

				M. R. Lovati, C. Manzoni, E. Gianazza, A. Arnoldi, E. Kurowska, K. K. Carroll, and C. R. Sirtori Soy Protein Peptides Regulate Cholesterol Homeostasis in Hep G2 Cells J. Nutr., October 1, 2000; 130(10): 2543 - 2549. [Abstract] [Full Text]

				C. L. Williams, M. C. Bollella, B. A. Strobino, L. Boccia, and L. Campanaro Plant Stanol Ester and Bran Fiber in Childhood: Effects on Lipids, Stool Weight and Stool Frequency in Preschool Children J. Am. Coll. Nutr., December 1, 1999; 18(6): 572 - 581. [Abstract] [Full Text] [PDF]

				J. R. Crouse III, T. Morgan, J. G. Terry, J. Ellis, M. Vitolins, and G. L. Burke A Randomized Trial Comparing the Effect of Casein With That of Soy Protein Containing Varying Amounts of Isoflavones on Plasma Concentrations of Lipids and Lipoproteins Arch Intern Med, September 27, 1999; 159(17): 2070 - 2076. [Abstract] [Full Text] [PDF]

				J. W. Anderson, B. M. Johnstone, and M. E. Cook-Newell Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids N. Engl. J. Med., August 3, 1995; 333(5): 276 - 282. [Abstract] [Full Text] [PDF]